U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS
This repository is under review for potential modification in compliance with Administration directives.

Details

Stereochemistry ACHIRAL
Molecular Formula C29H25F4N3O5S
Molecular Weight 603.585
Optical Activity UNSPECIFIED
Defined Stereocenters 3 / 3
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of TROPIFEXOR

SMILES

OC(=O)C1=CC2=C(N=C(S2)N3[C@H]4CC[C@@H]3C[C@@H](C4)OCC5=C(ON=C5C6=CC=CC=C6OC(F)(F)F)C7CC7)C(F)=C1

InChI

InChIKey=VYLOOGHLKSNNEK-PIIMJCKOSA-N
InChI=1S/C29H25F4N3O5S/c30-21-9-15(27(37)38)10-23-25(21)34-28(42-23)36-16-7-8-17(36)12-18(11-16)39-13-20-24(35-41-26(20)14-5-6-14)19-3-1-2-4-22(19)40-29(31,32)33/h1-4,9-10,14,16-18H,5-8,11-13H2,(H,37,38)/t16-,17+,18+

HIDE SMILES / InChI

Molecular Formula C29H25F4N3O5S
Molecular Weight 603.585
Charge 0
Count
Stereochemistry ABSOLUTE
Additional Stereochemistry No
Defined Stereocenters 3 / 3
E/Z Centers 0
Optical Activity UNSPECIFIED

Approval Year

Cmax

Cmax

ValueDoseCo-administeredAnalytePopulation
1.04 ng/mL
30 μg single, oral
dose: 30 μg
route of administration: Oral
experiment type: SINGLE
co-administered:
TROPIFEXOR plasma
Homo sapiens
population: UNHEALTHY
age: ADULT
sex: FEMALE / MALE
food status: UNKNOWN
1.25 ng/mL
30 μg 1 times / day steady-state, oral
dose: 30 μg
route of administration: Oral
experiment type: STEADY-STATE
co-administered:
TROPIFEXOR plasma
Homo sapiens
population: UNHEALTHY
age: ADULT
sex: FEMALE / MALE
food status: UNKNOWN
1.8 ng/mL
60 μg single, oral
dose: 60 μg
route of administration: Oral
experiment type: SINGLE
co-administered:
TROPIFEXOR plasma
Homo sapiens
population: UNHEALTHY
age: ADULT
sex: FEMALE / MALE
food status: UNKNOWN
2.55 ng/mL
60 μg 1 times / day steady-state, oral
dose: 60 μg
route of administration: Oral
experiment type: STEADY-STATE
co-administered:
TROPIFEXOR plasma
Homo sapiens
population: UNHEALTHY
age: ADULT
sex: FEMALE / MALE
food status: UNKNOWN
2.37 ng/mL
90 μg single, oral
dose: 90 μg
route of administration: Oral
experiment type: SINGLE
co-administered:
TROPIFEXOR plasma
Homo sapiens
population: UNHEALTHY
age: ADULT
sex: FEMALE / MALE
food status: UNKNOWN
4.3 ng/mL
90 μg 1 times / day steady-state, oral
dose: 90 μg
route of administration: Oral
experiment type: STEADY-STATE
co-administered:
TROPIFEXOR plasma
Homo sapiens
population: UNHEALTHY
age: ADULT
sex: FEMALE / MALE
food status: UNKNOWN
4.84 ng/mL
150 μg single, oral
dose: 150 μg
route of administration: Oral
experiment type: SINGLE
co-administered:
TROPIFEXOR plasma
Homo sapiens
population: UNHEALTHY
age: ADULT
sex: FEMALE / MALE
food status: UNKNOWN
6.37 ng/mL
150 μg 1 times / day steady-state, oral
dose: 150 μg
route of administration: Oral
experiment type: STEADY-STATE
co-administered:
TROPIFEXOR plasma
Homo sapiens
population: UNHEALTHY
age: ADULT
sex: FEMALE / MALE
food status: UNKNOWN
0.19 ng/mL
10 μg single, oral
dose: 10 μg
route of administration: Oral
experiment type: SINGLE
co-administered:
TROPIFEXOR plasma
Homo sapiens
population: HEALTHY
age: ADULT
sex: FEMALE / MALE
food status: FASTED
0.63 ng/mL
30 μg single, oral
dose: 30 μg
route of administration: Oral
experiment type: SINGLE
co-administered:
TROPIFEXOR plasma
Homo sapiens
population: HEALTHY
age: ADULT
sex: FEMALE / MALE
food status: FASTED
1.7 ng/mL
100 μg single, oral
dose: 100 μg
route of administration: Oral
experiment type: SINGLE
co-administered:
TROPIFEXOR plasma
Homo sapiens
population: HEALTHY
age: ADULT
sex: FEMALE / MALE
food status: FASTED
6.4 ng/mL
300 μg single, oral
dose: 300 μg
route of administration: Oral
experiment type: SINGLE
co-administered:
TROPIFEXOR plasma
Homo sapiens
population: HEALTHY
age: ADULT
sex: FEMALE / MALE
food status: FASTED
10.4 ng/mL
300 μg single, oral
dose: 300 μg
route of administration: Oral
experiment type: SINGLE
co-administered:
TROPIFEXOR plasma
Homo sapiens
population: HEALTHY
age: ADULT
sex: FEMALE / MALE
food status: FED
22.1 ng/mL
1000 μg single, oral
dose: 1000 μg
route of administration: Oral
experiment type: SINGLE
co-administered:
TROPIFEXOR plasma
Homo sapiens
population: HEALTHY
age: ADULT
sex: FEMALE / MALE
food status: FASTED
54.2 ng/mL
3000 μg single, oral
dose: 3000 μg
route of administration: Oral
experiment type: SINGLE
co-administered:
TROPIFEXOR plasma
Homo sapiens
population: HEALTHY
age: ADULT
sex: FEMALE / MALE
food status: FASTED
3.42 ng/mL
200 μg single, oral
dose: 200 μg
route of administration: Oral
experiment type: SINGLE
co-administered:
TROPIFEXOR plasma
Homo sapiens
population: HEALTHY
age: ADULT
sex: FEMALE / MALE
food status: FASTED
AUC

AUC

ValueDoseCo-administeredAnalytePopulation
4.98 ng × h/mL
30 μg single, oral
dose: 30 μg
route of administration: Oral
experiment type: SINGLE
co-administered:
TROPIFEXOR plasma
Homo sapiens
population: UNHEALTHY
age: ADULT
sex: FEMALE / MALE
food status: UNKNOWN
7.95 ng × h/mL
30 μg 1 times / day steady-state, oral
dose: 30 μg
route of administration: Oral
experiment type: STEADY-STATE
co-administered:
TROPIFEXOR plasma
Homo sapiens
population: UNHEALTHY
age: ADULT
sex: FEMALE / MALE
food status: UNKNOWN
12.1 ng × h/mL
60 μg single, oral
dose: 60 μg
route of administration: Oral
experiment type: SINGLE
co-administered:
TROPIFEXOR plasma
Homo sapiens
population: UNHEALTHY
age: ADULT
sex: FEMALE / MALE
food status: UNKNOWN
17.6 ng × h/mL
60 μg 1 times / day steady-state, oral
dose: 60 μg
route of administration: Oral
experiment type: STEADY-STATE
co-administered:
TROPIFEXOR plasma
Homo sapiens
population: UNHEALTHY
age: ADULT
sex: FEMALE / MALE
food status: UNKNOWN
23.4 ng × h/mL
90 μg 1 times / day steady-state, oral
dose: 90 μg
route of administration: Oral
experiment type: STEADY-STATE
co-administered:
TROPIFEXOR plasma
Homo sapiens
population: UNHEALTHY
age: ADULT
sex: FEMALE / MALE
food status: UNKNOWN
24.5 ng × h/mL
150 μg single, oral
dose: 150 μg
route of administration: Oral
experiment type: SINGLE
co-administered:
TROPIFEXOR plasma
Homo sapiens
population: UNHEALTHY
age: ADULT
sex: FEMALE / MALE
food status: UNKNOWN
44.2 ng × h/mL
150 μg 1 times / day steady-state, oral
dose: 150 μg
route of administration: Oral
experiment type: STEADY-STATE
co-administered:
TROPIFEXOR plasma
Homo sapiens
population: UNHEALTHY
age: ADULT
sex: FEMALE / MALE
food status: UNKNOWN
3.39 ng × h/mL
10 μg single, oral
dose: 10 μg
route of administration: Oral
experiment type: SINGLE
co-administered:
TROPIFEXOR plasma
Homo sapiens
population: HEALTHY
age: ADULT
sex: FEMALE / MALE
food status: FASTED
13.4 ng × h/mL
30 μg single, oral
dose: 30 μg
route of administration: Oral
experiment type: SINGLE
co-administered:
TROPIFEXOR plasma
Homo sapiens
population: HEALTHY
age: ADULT
sex: FEMALE / MALE
food status: FASTED
37.9 ng × h/mL
100 μg single, oral
dose: 100 μg
route of administration: Oral
experiment type: SINGLE
co-administered:
TROPIFEXOR plasma
Homo sapiens
population: HEALTHY
age: ADULT
sex: FEMALE / MALE
food status: FASTED
123 ng × h/mL
300 μg single, oral
dose: 300 μg
route of administration: Oral
experiment type: SINGLE
co-administered:
TROPIFEXOR plasma
Homo sapiens
population: HEALTHY
age: ADULT
sex: FEMALE / MALE
food status: FASTED
203 ng × h/mL
300 μg single, oral
dose: 300 μg
route of administration: Oral
experiment type: SINGLE
co-administered:
TROPIFEXOR plasma
Homo sapiens
population: HEALTHY
age: ADULT
sex: FEMALE / MALE
food status: FED
482 ng × h/mL
1000 μg single, oral
dose: 1000 μg
route of administration: Oral
experiment type: SINGLE
co-administered:
TROPIFEXOR plasma
Homo sapiens
population: HEALTHY
age: ADULT
sex: FEMALE / MALE
food status: FASTED
933 ng × h/mL
3000 μg single, oral
dose: 3000 μg
route of administration: Oral
experiment type: SINGLE
co-administered:
TROPIFEXOR plasma
Homo sapiens
population: HEALTHY
age: ADULT
sex: FEMALE / MALE
food status: FASTED
73.8 ng × h/mL
200 μg single, oral
dose: 200 μg
route of administration: Oral
experiment type: SINGLE
co-administered:
TROPIFEXOR plasma
Homo sapiens
population: HEALTHY
age: ADULT
sex: FEMALE / MALE
food status: FASTED
T1/2

T1/2

ValueDoseCo-administeredAnalytePopulation
14.9 h
10 μg single, oral
dose: 10 μg
route of administration: Oral
experiment type: SINGLE
co-administered:
TROPIFEXOR plasma
Homo sapiens
population: HEALTHY
age: ADULT
sex: FEMALE / MALE
food status: FASTED
13.7 h
30 μg single, oral
dose: 30 μg
route of administration: Oral
experiment type: SINGLE
co-administered:
TROPIFEXOR plasma
Homo sapiens
population: HEALTHY
age: ADULT
sex: FEMALE / MALE
food status: FASTED
13.5 h
100 μg single, oral
dose: 100 μg
route of administration: Oral
experiment type: SINGLE
co-administered:
TROPIFEXOR plasma
Homo sapiens
population: HEALTHY
age: ADULT
sex: FEMALE / MALE
food status: FASTED
15.3 h
300 μg single, oral
dose: 300 μg
route of administration: Oral
experiment type: SINGLE
co-administered:
TROPIFEXOR plasma
Homo sapiens
population: HEALTHY
age: ADULT
sex: FEMALE / MALE
food status: FASTED
12 h
300 μg single, oral
dose: 300 μg
route of administration: Oral
experiment type: SINGLE
co-administered:
TROPIFEXOR plasma
Homo sapiens
population: HEALTHY
age: ADULT
sex: FEMALE / MALE
food status: FED
21.9 h
1000 μg single, oral
dose: 1000 μg
route of administration: Oral
experiment type: SINGLE
co-administered:
TROPIFEXOR plasma
Homo sapiens
population: HEALTHY
age: ADULT
sex: FEMALE / MALE
food status: FASTED
16.5 h
3000 μg single, oral
dose: 3000 μg
route of administration: Oral
experiment type: SINGLE
co-administered:
TROPIFEXOR plasma
Homo sapiens
population: HEALTHY
age: ADULT
sex: FEMALE / MALE
food status: FASTED
Funbound

Funbound

ValueDoseCo-administeredAnalytePopulation
0.13%
200 μg single, oral
dose: 200 μg
route of administration: Oral
experiment type: SINGLE
co-administered:
TROPIFEXOR plasma
Homo sapiens
population: HEALTHY
age: ADULT
sex: FEMALE / MALE
food status: FASTED
Substance Class Chemical
Created
by admin
on Mon Mar 31 22:09:47 GMT 2025
Edited
by admin
on Mon Mar 31 22:09:47 GMT 2025
Record UNII
NMZ08KM76Z
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
TROPIFEXOR
INN  
INN   USAN  
Official Name English
tropifexor [INN]
Preferred Name English
LJN452
Code English
LJN-452
Code English
2-((1R,3R,5S)-3-((5-CYCLOPROPYL-3-(2-(TRIFLUOROMETHOXY)PHENYL)-1,2-OXAZOL-4-YL)METHOXY)-8- AZABICYCLO(3.2.1)OCTAN-8-YL)-4-FLUORO-1,3-BENZOTHIAZOLE-6-CARBOXYLIC ACID
Systematic Name English
Tropifexor [WHO-DD]
Common Name English
NVP-LJN452-NXA
Code English
6-BENZOTHIAZOLECARBOXYLIC ACID, 2-((3-ENDO)-3-((5-CYCLOPROPYL-3-(2- (TRIFLUOROMETHOXY)PHENYL)-4-ISOXAZOLYL)METHOXY)-8-AZABICYCLO(3.2.1)OCT-8- YL)-4-FLUORO-
Systematic Name English
TROPIFEXOR [USAN]
Common Name English
Classification Tree Code System Code
NCI_THESAURUS C78276
Created by admin on Mon Mar 31 22:09:47 GMT 2025 , Edited by admin on Mon Mar 31 22:09:47 GMT 2025
NCI_THESAURUS C2081
Created by admin on Mon Mar 31 22:09:47 GMT 2025 , Edited by admin on Mon Mar 31 22:09:47 GMT 2025
Code System Code Type Description
NCI_THESAURUS
C152764
Created by admin on Mon Mar 31 22:09:47 GMT 2025 , Edited by admin on Mon Mar 31 22:09:47 GMT 2025
PRIMARY
SMS_ID
100000176172
Created by admin on Mon Mar 31 22:09:47 GMT 2025 , Edited by admin on Mon Mar 31 22:09:47 GMT 2025
PRIMARY
FDA UNII
NMZ08KM76Z
Created by admin on Mon Mar 31 22:09:47 GMT 2025 , Edited by admin on Mon Mar 31 22:09:47 GMT 2025
PRIMARY
PUBCHEM
121418176
Created by admin on Mon Mar 31 22:09:47 GMT 2025 , Edited by admin on Mon Mar 31 22:09:47 GMT 2025
PRIMARY
INN
10443
Created by admin on Mon Mar 31 22:09:47 GMT 2025 , Edited by admin on Mon Mar 31 22:09:47 GMT 2025
PRIMARY
USAN
GH-47
Created by admin on Mon Mar 31 22:09:47 GMT 2025 , Edited by admin on Mon Mar 31 22:09:47 GMT 2025
PRIMARY
CAS
1383819-10-0
Created by admin on Mon Mar 31 22:09:47 GMT 2025 , Edited by admin on Mon Mar 31 22:09:47 GMT 2025
NON-SPECIFIC STEREOCHEMISTRY
CAS
1383816-29-2
Created by admin on Mon Mar 31 22:09:47 GMT 2025 , Edited by admin on Mon Mar 31 22:09:47 GMT 2025
PRIMARY
EPA CompTox
DTXSID001100225
Created by admin on Mon Mar 31 22:09:47 GMT 2025 , Edited by admin on Mon Mar 31 22:09:47 GMT 2025
PRIMARY
WIKIPEDIA
Tropifexor
Created by admin on Mon Mar 31 22:09:47 GMT 2025 , Edited by admin on Mon Mar 31 22:09:47 GMT 2025
PRIMARY
Related Record Type Details
TARGET -> AGONIST
EC50
Related Record Type Details
ACTIVE MOIETY